"Transcription Factors" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Endogenous substances, usually proteins, which are effective in the initiation, stimulation, or termination of the genetic transcription process.
| Descriptor ID |
D014157
|
| MeSH Number(s) |
D12.776.930
|
| Concept/Terms |
Transcription Factors- Transcription Factors
- Factors, Transcription
- Transcription Factor
- Factor, Transcription
|
Below are MeSH descriptors whose meaning is more general than "Transcription Factors".
Below are MeSH descriptors whose meaning is more specific than "Transcription Factors".
This graph shows the total number of publications written about "Transcription Factors" by people in this website by year, and whether "Transcription Factors" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1993 | 5 | 2 | 7 |
| 1994 | 6 | 0 | 6 |
| 1995 | 5 | 2 | 7 |
| 1996 | 14 | 3 | 17 |
| 1997 | 6 | 4 | 10 |
| 1998 | 8 | 3 | 11 |
| 1999 | 7 | 1 | 8 |
| 2000 | 9 | 4 | 13 |
| 2001 | 8 | 3 | 11 |
| 2002 | 17 | 8 | 25 |
| 2003 | 15 | 7 | 22 |
| 2004 | 8 | 7 | 15 |
| 2005 | 8 | 5 | 13 |
| 2006 | 10 | 4 | 14 |
| 2007 | 6 | 1 | 7 |
| 2008 | 8 | 2 | 10 |
| 2009 | 4 | 8 | 12 |
| 2010 | 7 | 5 | 12 |
| 2011 | 9 | 7 | 16 |
| 2012 | 11 | 3 | 14 |
| 2013 | 5 | 10 | 15 |
| 2014 | 8 | 14 | 22 |
| 2015 | 6 | 7 | 13 |
| 2016 | 5 | 4 | 9 |
| 2017 | 7 | 5 | 12 |
| 2018 | 5 | 3 | 8 |
| 2019 | 3 | 7 | 10 |
| 2020 | 3 | 3 | 6 |
| 2021 | 9 | 6 | 15 |
| 2022 | 1 | 5 | 6 |
To return to the timeline,
click here.
Below are the most recent publications written about "Transcription Factors" by people in Profiles.
-
Structural and Functional Characterization of Rv0792c from Mycobacterium tuberculosis: Identifying Small Molecule Inhibitor against HutC Protein. Microbiol Spectr. 2023 Feb 14; 11(1):e0197322.
-
Differential prognostic effect of systemic inflammation in patients with non-small cell lung cancer treated with immunotherapy or chemotherapy: A post hoc analysis of the phase 3 OAK trial. Cancer. 2022 08 15; 128(16):3067-3079.
-
Mouse Chd4-NURD is required for neonatal spermatogonia survival and normal gonad development. Epigenetics Chromatin. 2022 05 14; 15(1):16.
-
3JC48-3 (methyl 4'-methyl-5-(7-nitrobenzo[c][1,2,5]oxadiazol-4-yl)-[1,1'-biphenyl]-3-carboxylate): a novel MYC/MAX dimerization inhibitor reduces prostate cancer growth. Cancer Gene Ther. 2022 11; 29(11):1550-1557.
-
IL-1ß Impacts Vascular Integrity and Lymphatic Function in the Embryonic Omentum. Circ Res. 2022 02 04; 130(3):366-383.
-
Frankly Invasive Carcinoma Ex-intraductal Carcinoma: Expanding on an Emerging and Perplexing Concept in Salivary Gland Tumor Pathology. Head Neck Pathol. 2022 Sep; 16(3):657-669.
-
The role of distinct BRD4 isoforms and their contribution to high-grade serous ovarian carcinoma pathogenesis. Mol Cancer. 2021 11 10; 20(1):145.
-
NUTM1-Rearranged Neoplasms-A Heterogeneous Group of Primitive Tumors with Expanding Spectrum of Histology and Molecular Alterations-An Updated Review. Curr Oncol. 2021 11 07; 28(6):4485-4503.
-
Deficiencies in the DNA Binding Protein ARID3a Alter Chromatin Structures Important for Early Human Erythropoiesis. Immunohorizons. 2021 10 18; 5(10):802-817.
-
Pediatric Metastatic Hepatoblastoma With an ARID1A Mutation and Rhabdoid Cells. Int J Surg Pathol. 2022 May; 30(3):307-312.